Clinical practice guideline: The prophylaxis of venous thromboembolism;Prophylaxe der venösen Thromboembolie

Deutsches Arzteblatt International

Volumn 113, Issue 31-32, 2016, Pages 532-538

  Encke, Albrecht ^a   Haas, Sylvia ^a   Kopp, Ina ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; PRACTICE GUIDELINE; VENOUS THROMBOEMBOLISM; CARDIOLOGY; COMPRESSION STOCKING; EVIDENCE BASED MEDICINE; GERMANY; POSTOPERATIVE COMPLICATION; STANDARDS; TREATMENT OUTCOME;

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANTS; CARDIOLOGY; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; GERMANY; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; STOCKINGS, COMPRESSION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84983360226     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2016.0532     Document Type: Article

References (40)

1. Tagalakis V, Patenaude V, Kahn S.R., Suissa S: Incidence of and mortality from venous thromboembolism in a real-world population: The Q-VTE Study Cohort. Am J Med 2013; 126: e13-23.
2. Silverstein MD, Heit JA, Mohr D.N., Petterson TM, O'Fallon WM, Melton WM: Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-93.
3. Alikhan R, Peters F, Willmitt R., Cohen AT: Fatal pulmonary embolism in hospitalized patients: a necropsy review. J Clin Pathol 2004; 57: 1254-7.
4. Sandler DA, Martin JF: Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203-5.
5. Geerts WH, Pineo G F, Heit JA, et al: Prevention of venous thromboem-bolism: the Seventh ACCP Conference on Antithrombotic and Thrombo-lytic Therapy. Chest 2004; 126 (3 Suppl): 338S-400S.
6. thedition. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141; e227S-e277S.
7. thedition. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 14; e195S-e226S.
8. Cohen AT, Tapson V F, Bergmann J F, et al.: Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-94.
9. OECD (2015), Health at a Glance 2015: OECD Indicators, OECD Publishing, Paris. dx.doi.org/10.1787/health-glance-2015-en (last accessed on 5 July 2016).
10. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF - Ständige Kommission Leitlinien). AWMF-Regelwerk "Leitlinien". 1. Auflage 2012. www.awmf.org/leitlinien/awmf-regelwerk.html (last accessed on 5 July 2016).
11. Encke A, Haas, S, Sauerland S., et al.: S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE). Vasa 2009; 38: 1-131.
12. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
13. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE) - 2. komplett überarbeitete Auflage (Stand 15.10. 2015). www.awmf.org/leitlinien/detail/11/003-001.html (last accessed on 5 July 2016).
14. Higgins J.P., Altman DG, Gøtzsche PC, et al.: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
15. thedition. ACCP. Evidence Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): 7S-47S.
16. National Institute for Health and Clinical Excellence (NICE): Venous thromboembolism: reducing the risk. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline 92. 2010. www.nice.org.uk/guidance/cg92/resources/guidance-venous-thromboembolismreducing-the-risk-pdf (last accessed on 20 June 2015).
17. Lyman GH, Khorana AA, Kuderer N.M., et al.: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2189-204.
18. Royal College of Obstetricians and Gynecologists: Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top Guideline No. 37a. 2015. www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a (last accessed on 5 July 2016).
19. Waurick K, Riess H, Van Aken H, et al.: Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/antithrombotische Medikation. 3. überarbeitete Empfehlung der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin. Anaesth Intensivmed 2014; 55: 464-92.
20. National Institute for Health and Clinical Excellence (NICE): Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults. NICE technology appraisal guidance 245, 2012. www.nice.org.uk/search?q=ta245 (last accessed July 5 2016).
21. Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG): Apixaban - Nutzenbewertung nach §35a SGBV. Auftrag A11-30, 2012. www.iqwig.de/de/projekte-ergebnisse/projekte/arzneimittelbewertung/a11-30-apixaban-nutzenbewertung-gemass-35a-sgb-v-dossier-bewertung.2140.html (last accessed 5 July 2016).
22. Eppsteiner RW, Shin JJ, Johnson J, et al: Mechanical compression v ersus subcutaneous heparin therapy in postoperative and posttrauma patients: A systematic review and meta-analysis. World J Surg 2010; 34: 10-9.
23. Sachdeva A, Dalton M, Amaragiri S V, et al.: Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2014; 12: CD001484.
24. CLOTS (Clots in Legs Or Stockings after Stroke) Trials Collaboration: Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 2009; 373: 1958-65.
25. Wade R, Sideris E, Fiona Paton F, et al.: Graduated compression stockings for the prevention of deep-vein thrombosis in postoperative surgical patients: a systematic review and economic model with a value of information analysis. Health Technol Assess 2015; 19: 1-220.
26. Haas S, Holberg G, Kreutz R., et al.: The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17.701 patients in the XAMOS study. Vasc Health Risk Manag 2016; 12: 209-18.
27. Sajid MS, Desai M, Morris R.W., et al.: Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients. Cochrane Database Syst Rev 2012; CD007162(5).
28. Sajid MS, Desai M, Morris R.W., et al.: Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients. Cochrane Database Syst Rev 2012; CD007162(5).
29. Ho KM, Tan JA: Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation 2013; 128: 1003-20.
30. Collen J.F., Jackson JL, Shorr A.F., et al.: Prevention of venous thrombo-embolism in neurosurgery: ametaanalysis. Chest 2008; 134: 237-49.
31. Almaggi A, Simonetti G, Trevisan E., et al.: Perioperative thromboprophy-laxis in patients with craniotomy for brain tumours: a systematic review. J Neurol Oncol 2013; 113: 293-303.
32. Bottaro FJ, Elizondo MC, Doti C, et al: Efficacy of extended thrombo-prophylaxis in major abdominal surgery: What does the evidence show? A meta-analysis. Thromb Haemost 2008; 99: 1104-11.
33. Hull RD, Pineo G F, Stein PD, et al: Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001; 135: 858-69.
34. Eriksson BI, Borris LC, Friedman R.J., et al.: Rivaroxaban versus enoxa-parin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358: 2765-75.
35. Eriksson BI, Dahl OE, Huo M.H., et al.: Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II): A randomised, double-blind, non-inferiority trial. Thromb Haemost 2011; 105: 721-9.
36. Kakkar AK, Brenner B, Dahl O.E., et al.: Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboem-bolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372: 31-9.
37. Lassen MR, Gallus A, Raskob G.E., et al.: Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. New Eng J Med 2010; 363: 2487-98.
38. National Institute for Health and Clinical Excellence (NICE): Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults. NICE technology appraisal guidance 157. www.nice.org.uk/guidance/ta157 (last accessed on 5 July 2016).
39. National Institute for Health and Clinical Excellence (NICE): Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. NICE technology appraisal guidance 170. www.nice.org.uk/guidance/ta170 (last accessed on 5 July 2016).
40. Alikhan R, Bedenis R, Cohen AT: Heparin for the prevention of venous thromboembolismin acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev 2014: CD003747.
41. Alikhan R, Bedenis R, Cohen AT: Heparin for the prevention of venous thromboembolismin acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev 2014: CD003747.
42. Alhazzani W, Lim W, Jaeschke R.Z., et al.: Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 2013; 41: 2088-98.